Silencing HoxBlinc using shRNA in AML cells reduced the expression of homeotic oncogenes, including HOXA9, MEIS1, KIT, and JAK2, and impaired the NUP98-HOXA9 fusion gene signature. Here, HOXA9 is linked to acute myeloid leukemia.